Document is current

Article History

Received: 15 December 2024

Accepted: 2 April 2025

First Online: 11 April 2025

Declarations

:

: The study was conducted after getting the approval of the Medical Research Ethics Committee of the National Research Centre with an ethical registration approval number of 16124. A written informed consent was taken from the participants enrolled in the study. For participants who were unable to write, a right thumbprint was used as a signature to take informed consent. This procedure has been approved by the above-mentioned ethics committee. The study was fully voluntary, and participants were well informed about their rights to withdraw at any time. Data was collected confidentially. Data was de-identified and stored in a safe location. All methods were carried out following the declaration of Helsinki. The conduct of the study complied with the International Ethical Guidelines for Biomedical Research Involving Human Subjects []. The information disclosure for “Making sure patients understand” was guaranteed according to the recommendations of the Egyptian patients and guardians’ perception that clinical informed consent is the preferred purpose for Informed Consent practices [104].

: Non-applicable.

: All authors report no conflict of interest. No financial or non-financial benefits have been received or will be received from any party related directly or indirectly to the subject of this manuscript.